Economic evaluations in the critical care literature: Do they help us improve the efficiency of our unit?

Critical Care Medicine

Volumn 24, Issue 9, 1996, Pages 1591-1598

  Heyland, Daren K ^a,b   Kernerman, Phil ^a   Gafni, Amiram ^b,c   Cook, Deborah J ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

cost containment; cost benefit analysis; cost effectiveness; critical appraisal; critical care; economic evaluations; healthcare costs; intensive care unit

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH ECONOMICS; INTENSIVE CARE; MEDICAL LITERATURE; PRIORITY JOURNAL;

EID: 0029833369     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199609000-00025     Document Type: Article

References (46)

1. Eddy DM: Clinical decision-making: From theory to practice. Three battles to watch in the 1990s. JAMA 1993; 270: 520-526
2. Cullen DJ: Results and costs of intensive care. Anesthesiology 1977; 47: 203-216
3. Cullen DJ, Keene R, Waternaux C, et al: Results, charges and benefits of intensive care for critically ill patients: Update 1983. Crit Care Med 1984; 12: 102-106
4. Turnbull AD, Carlon G, Baron R, et al: The inverse relationship between cost and survival in the critically ill cancer patient. Crit Care Med 1979; 7:20-23
5. Jacobs P, Noseworthy TW: National estimates of intensive care utilization and costs: Canada and United States. Crit Care Med 1990; 18:1282-1286
6. Detsky AS, Stricker SC, Mulley AG, et al: Prognosis, survival, and the expenditure of hospital resources for patients in an intensive care unit. N Engl J Med 1981; 305:667-672
7. Evidence-Based Medicine Working Group: Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA 1992; 268:2420-2425
8. Warner K, Hutton RC: Cost-benefit and cost-effectiveness analysis in the health care literature: Growth and composition of the literature. Med Care 1980; 18:1069-1084
9. Elixhauser A, Luce BR, Taylor WR, et al: Health Care CBA/CEA: An update on the growth and composition of the literature. Med Care 1993; 31:JS1-JS11
10. Drummond MF, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. Oxford, Oxford University Press, 1987, pp 18-35
11. Stoddart GL, Drummond MF: How to read clinical journals: VII. To understand an economic evaluation. Can Med Assoc J 1984; 130:1428-1433
12. Udvarhelyi S, Colditz GA, Rai A, et al: Cost-effectiveness and cost-benefit analyses in the medical literature: Are the methods being used correctly? Ann Intern Med 1992; 116:238-244
13. Guyatt G, Sackett DL, Cook DJ, et al: Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results valid? JAMA 1993; 270:2598-2601
14. Finkler SA: The distinction between cost and charges. Ann Intern Med 1992; 96:102-107
15. Guyatt G, Sackett DL, Cook DJ, et al: Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients. JAMA 1994; 271:59-63
16. Shoemaker WC, Kram HB, Appel PL, et al: The efficacy of central venous and pulmonary artery catheters and therapy based upon them in reducing mortality and morbidity. Arch Surg 1990; 125:1332-1338
17. Read JL, Quinn RJ, Berwick DM, et al: Preference for health outcomes: Comparison of assessment methods. Med Decis Making 1984; 4:315-329
18. Hornberger JC, Redelmeier DA, Peterson J: Variability among methods to assess patients' well being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 1992; 45: 505-512
19. Krahn M, Gafni A: Discounting in the economic evaluation of health care interventions. Med Care 1993; 31:403-418
20. Newman RH: Bedside blood sugar determinations in the critically ill. Heart Lung 1988; 17:667-679
21. Luce BR, Ellrodt AG, Cameron JM, et al: Managing acute hypertension: Cost considerations. Am J Emerg Med 1985; 3(Suppl 6):31-34
22. Loop FD, Christiansen EK, Lester JL, et al: A strategy for cost containment in coronary surgery. JAMA 1983; 250: 63-66
23. Hadbavny AM, Hoyt JW: Promotion of cost-effective benzodiazepine sedation. Am J Hosp Pharm 1993; 50:660-661
24. Carrasco G, Molina R, Costa J, et al: Propofol vs. Midazolam in short-, medium-, and long-term sedation of critically ill patients: A cost-benefit analysis. Chest 1993; 103:557-564
25. Sadowski DA, Pohlman S, Maley MP, et al: Use of nonsterile gloves for routine noninvasive procedures in thermally injured patients. J Burn Care Rehabil 1988; 9:613-615
26. Burke KG, Larson E, Maciorowski L, et al: Evaluation of the sterility of thermodilution room-temperature injectate preparations. Crit Care Med 1986; 14:503-504
27. Fracassi J: ICU flowsheets: Are they cost-effective? Nurs Manager 1987; 18:66-67
28. Gross PA, Van Antwerpen Cl, Hess WA, et al: Use and abuse of blood cultures: Program to limit use. Am J Infect Control 1988; 16:114-117
29. Pemberton LB, Schaefer N, Goehring L, et al: Oral ranitidine as prophylaxis for gastric stress ulcers in intensive care unit patients: Serum concentrations and cost comparisons. Crit Care Med 1993; 21:339-342
30. Yonkman CA, Hamory BH: Comparison of three methods of maintaining a sterile injectate system during cardiac output determinations. Am J Infect Control 1984; 12:276-281
31. Civetta JM, Hudson-Civetta JA: Maintaining quality of care while reducing charges in the ICU: Ten ways. Ann Surg 1985; 202; 524-530
32. Roberts DE, Bell DD, Ostryzniuk T, et al: Eliminating needless testing in intensive care: An information-based team management approach. Crit Care Med 1993; 21:1452-1458
33. Ahrens TS, Padwojski A: Economic effectiveness of an advanced nurse clinician model. Nurs Manager 1990; 21:72J, 72N, 72P
34. Chalfin DB, Holbein ME, Fein AM, et al: Cost-effectiveness of monoclonal antibodies to Gram-negative endotoxin in the treatment of Gram-negative sepsis in ICU patients. JAMA 1993; 269: 249-254
35. Shoemaker WC, Kram HB, Appel PL, et al: The efficacy of central venous and pulmonary artery catheters and therapy based upon them in reducing mortality and morbidity. Arch Surg 1990; 125:1332-1338
36. Vander Salm TJ, Blair SA: Effect of reduction of postoperative days in the intensive care unit after coronary artery bypass. J Thorac Cardiovasc Surg 1984; 88:558-561
37. Bilen Z, Weinberg PF, Gowani Y, et al: Clinical utility and cost-effectiveness of protective sleeve pulmonary artery catheters. Crit. Care Med 1991; 19:491-496
38. Jastremski MS, Chelluri L, Beney KM, et al: Analysis of the effects of continuous on-line monitoring of mixed venous oxygen saturation on patient outcome and cost-effectiveness. Crit Care Med 1989; 17:148-153
39. Inman KJ, Sibbald WJ, Rutledge FS, et al: Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers. JAMA 1993; 269:1139-1143
40. Birch S, Gafni A: Cost effectiveness/ utility analyses: Do current decision rules lead us to where we want to be? J Health Econ 1992; 11:279-296
41. Knaus WA, Wagner DP, Zimmerman JE, et al: Variations in mortality and length of stay in intensive care units. Ann Intern Med 1993; 118:753-761
42. Schapira DV: Intensive care, survival, and expense of treating critically ill patients. JAMA 1993; 269:783-786
43. Thoner J: Outcome and costs of intensive care. A follow-up study on patients requiring prolonged mechanical ventilation. Acta Anaesthesiol Scand 1987; 31:693-698
44. Birch S, Gafni A: Cost-effectiveness ratios: In a league of their own. Health Policy 1994; 28:133-141
45. Drummond M, Brandt A, Luce B, et al: Standardizing methodologies for economic evaluation in health care: Practice, problems and potential. Int J Technol Assess Health Care 1993; 9: 26-36
46. Torrence GW: Health states worse than death. In: Third International Conference on Systems Science in Health Care, won Eimeren W, Engelbrecht R, Flagle CD (Eds). Berlin, Springer Verlag, 1984